Cart
sales@molnova.com
Adenosine antagonist-1
CAS No. 431040-19-6
Adenosine antagonist-1( —— )
Catalog No. M32770 CAS No. 431040-19-6
Adenosine antagonist-1 acts as an adenosine A3 receptor (AA3R) antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 377 | Get Quote |
|
| 5MG | 595 | Get Quote |
|
| 10MG | 845 | Get Quote |
|
| 25MG | 1187 | Get Quote |
|
| 50MG | 1500 | Get Quote |
|
| 100MG | 1782 | Get Quote |
|
| 200MG | 2511 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAdenosine antagonist-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdenosine antagonist-1 acts as an adenosine A3 receptor (AA3R) antagonist.
-
DescriptionAdenosine antagonist-1 is an adenosine A3 receptor (AA3R) antagonist.
-
In VitroAdenosine antagonist-1 (compound 22) is an adenosine A3 receptor (AA3R) antagonist.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAdenosine Receptor
-
RecptorAdenosine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number431040-19-6
-
Formula Weight359.41
-
Molecular FormulaC18H13N7S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1N(C2=C(N=C(NC=3C=NC=CN3)S2)C4=CC(C#N)=CC=C4)C=CN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. de Graaf C, et al. Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screenin. Proteins. 2008 May 1;71(2):599-620.?
molnova catalog
related products
-
N6-Cyclopentyladenos...
N6-Cyclopentyladenosine (CPA) is a selective agonist of the adenosine A1 receptor, mimicking its action with Ki values of 2.3 nM, 790 nM, and 43 nM for human A1, A2A, and A3 receptors, respectively.
-
CGS 21680 hydrochlor...
CGS 21680 is a specific adenosine A2A subtype receptor agonist with Ki of 27 nM.
-
Evodenoson
Evodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors.
